Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.58 |
| ▸ | GRM6 | O15303 | 1/20 | 0.58 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.58 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.58 |
| ▸ | GRM5 | P41594 | 1/20 | 0.58 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.58 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.58 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.58 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.58 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL154380 | 1.00 | GSR (0.58) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL358758 | 1.00 | GSR (0.58) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL8587639 | 0.92 | PMP22 (0.52) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Phosphoric Acid SCHEMBL8519189 | 0.92 | GRM8 (0.50) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL14423586 | 0.88 | GSR (0.50) | GSRGRM8GRM6GRIN2DGRIN3B | |
| Lysine SCHEMBL4561856 | 0.88 | GSR (0.67) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL19774715 | 0.87 | SLC1A1 (0.48) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL22186668 | 0.85 | GRM8 (0.56) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL5198612 | 0.83 | GRM8 (0.54) | GSRGRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL1769601 | 0.83 | OTC (0.45) | GSRGRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2141 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161408-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2025-05-22 | — | — | US | claimed |
| CN-115927217-B | Gamma-glutamylmethylamine synthetase mutant and application thereof | 河北远大九孚生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-4482852-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2025-01-01 | — | — | EP | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| WO-2023161211-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-31 | — | — | WO | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| EP-4230645-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-23 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| CN-113151198-B | Gamma-glutamine synthetase mutant, coding gene, amino acid sequence and application thereof | 大连医诺生物股份有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-113151199-B | Gamma-glutamine synthetase mutant with thermal stability, coding gene, amino acid sequence and application thereof | 大连医诺生物股份有限公司 | 2023-04-11 | — | — | CN | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
| EP-1411965-A4 | METHODS AND COMPOSITIONS FOR CONTROLLING PROTEIN ASSEMBLY OR AGGREGATION | NOVACTYL INC (US) | 2006-01-11 | — | — | EP | claimed |
| EP-1411965-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING PROTEIN ASSEMBLY OR AGGREGATION | Novactyl, Inc. (US) | 2004-04-28 | — | — | EP | claimed |
| WO-2003006044-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING PROTEIN ASSEMBLY OR AGGREGATION | NOVACTYL, INC. (US) | 2003-01-23 | — | — | WO | claimed |
| US-20020037908-A1 | Methods and compositions for controlling protein assembly or aggregation | NOVACTYL, INC. | 2002-03-28 | — | — | US | claimed |
| US-5302604-A | Squalene synthetase inhibitors, anticarcinogenic agents, zaragozic acid derivatives | MERCK & CO., INC. (US) | 1994-04-12 | — | — | US | claimed |
| US-5294627-A | Anticholesterol | MERCK & CO., INC. (US) | 1994-03-15 | — | — | US | claimed |
| WO-1993017557-A1 | CHOLESTEROL LOWERING COMPOUNDS PRODUCED BY DIRECTED BIOSYNTHESIS | MERCK & CO., INC. (US) | 1993-09-16 | — | — | WO | claimed |